KIR3DL1 and B-cell chronic lymphocytic leukemia: Furthermore, CLL and ALL patients show a selective down-regulation of non-Bw4 HLA-molecules (HLA-A and -B molecules with the Bw4 motif are ligands for inhibitory KIR)[6]–a mechanism which impairs both, NK and T-cell activity.